OU Medicine Inc., OK 2018B-C Bond Rating Raised To 'BB' On Profitability And Expected Cash Growth - S&P Global Ratings’ Credit Research

OU Medicine Inc., OK 2018B-C Bond Rating Raised To 'BB' On Profitability And Expected Cash Growth

OU Medicine Inc., OK 2018B-C Bond Rating Raised To 'BB' On Profitability And Expected Cash Growth - S&P Global Ratings’ Credit Research
OU Medicine Inc., OK 2018B-C Bond Rating Raised To 'BB' On Profitability And Expected Cash Growth
Published Aug 19, 2024
2 pages (1075 words) — Published Aug 19, 2024
Price US$ 150.00  |  Buy this Report Now

About This Report

  
Abstract:

DALLAS (S&P Global Ratings) Aug. 19, 2024--S&P Global Ratings raised its long-term rating on the Oklahoma Development Finance Authority's series 2018B tax-exempt fixed-rate bonds and series 2018C taxable fixed-rate bonds to 'BB' from 'BB-'. The bonds were issued for OU Medicine Inc. (OUMI), now doing business as OU Health. In addition, we also raised our underlying rating (SPUR) on the insured maturities of the authority's series 2018B and 2018C bonds, also issued for OUMI, to 'BB' from 'BB-'. "The upgrade reflects OU Health's healthy operating profitability with further growth in cash flow expected over the outlook period," said S&P Global Ratings credit analyst Patrick Zagar. "This has supported incremental improvement in year-end unrestricted reserves and we anticipate that trend will

  
Brief Excerpt:

...August 19, 2024 DALLAS (S&P Global Ratings) Aug. 19, 2024--S&P Global Ratings raised its long-term rating on the Oklahoma Development Finance Authority's series 2018B tax-exempt fixed-rate bonds and series 2018C taxable fixed-rate bonds to '##' from '##-'. The bonds were issued for OU Medicine Inc. (OUMI), now doing business as OU Health. In addition, we also raised our underlying rating (SPUR) on the insured maturities of the authority's series 2018B and 2018C bonds, also issued for OUMI, to '##' from '##-'. "The upgrade reflects OU Health's healthy operating profitability with further growth in cash flow expected over the outlook period," said S&P Global Ratings credit analyst Patrick Zagar. "This has supported incremental improvement in year-end unrestricted reserves and we anticipate that trend will continue, aided by increased Medicaid reimbursement under a new rate enhancement program and tapering capital spending."...

  
Report Type:

Ratings Action

Issuer
Sector
Global Issuers, Public Finance, Structured Finance
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "OU Medicine Inc., OK 2018B-C Bond Rating Raised To 'BB' On Profitability And Expected Cash Growth" Aug 19, 2024. Alacra Store. Nov 07, 2026. <http://www.alacrastore.com/s-and-p-credit-research/OU-Medicine-Inc-OK-2018B-C-Bond-Rating-Raised-To-BB-On-Profitability-And-Expected-Cash-Growth-3232763>
  
APA:
S&P Global Ratings’ Credit Research. (). OU Medicine Inc., OK 2018B-C Bond Rating Raised To 'BB' On Profitability And Expected Cash Growth Aug 19, 2024. New York, NY: Alacra Store. Retrieved Nov 07, 2026 from <http://www.alacrastore.com/s-and-p-credit-research/OU-Medicine-Inc-OK-2018B-C-Bond-Rating-Raised-To-BB-On-Profitability-And-Expected-Cash-Growth-3232763>
  
US$ 150.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Residential Mortgage-Backed Securities from one place.